Health
Recipients testing positive in Israel sparks concern over Pfizer vaccine efficacy – Global Times
More than 12,400 in Israel were reportedly infected after accepting Pfizer’s COVID-19 vaccine, which led to doubts over the vaccine’s efficacy, despite the reported…
An illustration shows vials of a COVID-19 vaccine and syringes with the logos of US pharmaceutical company Pfizer and German partner BioNTech. Photo: AFP
More than 12,400 in Israel were reportedly infected after accepting Pfizer’s COVID-19 vaccine, which led to doubts over the vaccine’s efficacy, despite the reported 95 percent efficacy in Phase III clinical trials.
This can be a sign that the vaccine’s efficacy is not necessarily the same as data from experiments, which is affected by many elements…
-
Business20 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
Business20 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
Noosa News12 hours agoPeregian Square revitalised | Noosa Today
-
General19 hours agoUsman Khawaja describes Perth Stadium pitch for first Ashes Test as ‘piece of shit’